EMCURE PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Emcure Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.09₹ -14.6
As on Oct 31, 2025, 4:01 PM IST
Emcure Pharmaceuticals Price Performance
Today's LowToday's High
₹1,313.00₹1,344.90
₹1,320.50
52 Weeks' Low52 Weeks' High
₹890.00₹1,524.85
₹1,320.50
Open Price
₹1,325.00
Prev. Close
₹1,335.10
Volume
3,064
Over the last 5 years, the share price of Emcure Pharmaceuticals has declined 0.57% CAGR. Over the past year, the corresponding return has been -8.60%.
Emcure Pharmaceuticals’s current P/E of 33.64x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Emcure Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Emcure Pharmaceuticals | -2.66 | 1.15 | -6.22 | 29.26 | -8.60 | -0.95 | -0.57 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Emcure Pharmaceuticals has declined 8.60% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Emcure Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,361.85 | 1,343.33 |
| 10 | 1,357.94 | 1,351.22 |
| 20 | 1,359.66 | 1,355.95 |
| 50 | 1,376.82 | 1,359.49 |
| 100 | 1,364.22 | 1,337.75 |
| 200 | 1,238.9 | 1,326.25 |
Emcure Pharmaceuticals Share Holding Pattern
In the latest quarter, Emcure Pharmaceuticals saw a drop in promoter holding to 77.87%, while DII stake increased to 4.36%, FII holding rose to 3.29%, and public shareholding moved down to 14.46% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Emcure Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 10,55,602 | 0.89 | 135.11 | |
| 10,00,000 | 0.27 | 127.99 | |
| 4,83,926 | 0.54 | 61.94 | |
| 4,70,272 | 0.74 | 60.19 | |
| 4,45,701 | 0.92 | 57.05 | |
| 2,93,137 | 0.57 | 37.52 | |
| 2,75,555 | 0.62 | 35.27 | |
| 2,09,774 | 0.55 | 26.85 | |
| 1,28,677 | 0.52 | 16.47 | |
| 89,388 | 0.3 | 11.44 |
* Excluding Index & Arbitrage Funds
Emcure Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 18, 2025, 12:18 AM IST | Emcure Pharmaceutica - Announcement under Regulation 30 (LODR)-Credit Rating |
| Oct 10, 2025, 7:13 PM IST | Emcure Pharmaceutica - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio |
| Oct 09, 2025, 12:11 AM IST | Emcure Pharmaceutica - Announcement under Regulation 30 (LODR)-Credit Rating |
| Oct 08, 2025, 9:27 PM IST | Emcure Pharmaceutica - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 08, 2025, 12:23 AM IST | Emcure Pharmaceutica - Intimation Of Withdrawal Of Re-Classification Application Under Regulation 31A Of SEBI (Listing Obliga |
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231PN1981PLC024251 and registration number is 024251. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 4381.92 Cr. and Equity Capital is Rs. 189.48 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. P-1 & P-2, IT-BT Park, Phase II, Pune Maharashtra 411057
- Contact
Management
- Mr. Berjis Minoo DesaiChairman & Non-Exe.Director
- Mr. Satish Ramanlal MehtaManaging Director & CEO
- Mr. Sunil Rajanikant MehtaWhole Time Director
- Ms. Namita Vikas ThaparWhole Time Director
- Mr. Samit Satish MehtaWhole Time Director
- Dr. Mukund Keshao GurjarWhole Time Director
- Mr. Vijay Keshav GokhaleIndependent Director
- Mr. Palamadai Sundararajan JayakumarIndependent Director
- Dr. Vidya Rajiv YeravdekarIndependent Director
- Dr. Shailesh Kripalu AyyangarIndependent Director
FAQs on Emcure Pharmaceuticals Share Price
What is the share price of Emcure Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Emcure Pharmaceuticals is ₹1,320.50 as on Oct 31, 2025.
What kind of stock is Emcure Pharmaceuticals?
The Emcure Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Emcure Pharmaceuticals?
The market cap of Emcure Pharmaceuticals is ₹25,032.04 Cr as on Oct 31, 2025.
What are today's High and Low prices of Emcure Pharmaceuticals?
Today’s highest and lowest price of Emcure Pharmaceuticals are ₹1,344.90 and ₹1,313.00.
What are the 52 Week High and 52 Week Low of Emcure Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Emcure Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Emcure Pharmaceuticals is ₹1,524.85 and 52-week low of Emcure Pharmaceuticals is ₹890.00 as on Oct 31, 2025.
How has the Emcure Pharmaceuticals performed historically in terms of returns?
The Emcure Pharmaceuticals has shown returns of -1.09% over the past day, 1.15% for the past month, -6.22% over 3 months, -8.6% over 1 year, -0.95% across 3 years, and -0.57% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Emcure Pharmaceuticals?
P/E ratio of and PB ratio of Emcure Pharmaceuticals are 33.64 and 6.08 on Oct 31, 2025. While the company gives a dividend yield of 0.23 per annum.
Emcure Pharmaceuticals News
✕
Market Pulse